WCA
REGN icon

Westover Capital Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Westover Capital Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-320
Closed -$203K – 240
2025
Q1 		$203K Hold
320
– – 0.05% 230
2024
Q4 		$228K Hold
320
– – 0.05% 216
2024
Q3 		$336K Hold
320
– – 0.06% 192
2024
Q2 		$336K Hold
320
– – 0.09% 164
2024
Q1 		$308K Hold
320
– – 0.09% 142
2023
Q4 		$281K Hold
320
– – 0.09% 146
2023
Q3 		$263K Hold
320
– – 0.1% 149
2023
Q2 		$230K Hold
320
– – 0.08% 164
2023
Q1 		$263K Hold
320
– – 0.1% 140
2022
Q4 		$231K Hold
320
– – 0.09% 138
2022
Q3 		$220K Buy
+320
New +$201K 0.08% 145

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return